Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients

No studies have been reported on the efficacy and safety of long-term ( ≥12 months) use of topical tacrolimus for refractory ocular surface inflammation in pediatric patients.

Source: BMC Ophthalmology - June 5, 2021 Category: Opthalmology Authors: Kyungmin Koh, Ikhyun Jun, Tae-im Kim, Eung Kweon Kim and Kyoung Yul Seo Tags: Research Source Type: research